Published in Immunity on October 01, 1995
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med (1998) 5.24
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med (2005) 3.22
Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol (2008) 3.11
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34
Mechanisms maintaining peripheral tolerance. Nat Immunol (2009) 2.14
Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol (2010) 2.08
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J Exp Med (2011) 1.94
High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. J Exp Med (2011) 1.76
Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J Exp Med (1997) 1.73
Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med (1998) 1.70
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med (2009) 1.66
CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med (2003) 1.63
Negative selection during the peripheral immune response to antigen. J Exp Med (2001) 1.59
Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2001) 1.56
Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest (1999) 1.53
Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov (2013) 1.50
Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other". Crit Rev Immunol (2000) 1.47
Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion. J Exp Med (2011) 1.45
Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest (2008) 1.44
The effects of TLR activation on T-cell development and differentiation. Clin Dev Immunol (2012) 1.33
CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc Natl Acad Sci U S A (2005) 1.27
Modeling the heterogeneity of multiple sclerosis in animals. Trends Immunol (2013) 1.25
Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments. J Immunol (2008) 1.20
In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med (2000) 1.17
Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun (2014) 1.15
Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med (2000) 1.14
Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics. J Immunol (2011) 1.10
Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells. PLoS One (2012) 1.10
Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur J Immunol (2006) 1.07
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing. J Exp Med (1997) 1.07
Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Diabetes (2008) 1.07
Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J Exp Med (1997) 1.04
Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade. Expert Rev Anticancer Ther (2012) 1.03
Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J Clin Invest (1997) 1.03
Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr Opin Immunol (2007) 1.03
Immune tolerance in multiple sclerosis. Immunol Rev (2011) 1.03
Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function. J Immunol (2006) 1.02
Pathogenic CD8 T cells in multiple sclerosis and its experimental models. Front Immunol (2012) 1.01
Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source. J Immunol (2012) 0.99
Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE. J Neuroimmunol (2009) 0.98
The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J Exp Med (1999) 0.98
Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur J Immunol (2010) 0.98
HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives. J Immunol (2012) 0.97
Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proc Natl Acad Sci U S A (2009) 0.96
CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire. Proc Natl Acad Sci U S A (2012) 0.95
A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L. J Immunol (2004) 0.95
Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft. J Exp Med (1998) 0.94
Restricted MHC-peptide repertoire predisposes to autoimmunity. J Exp Med (2005) 0.93
T-bet Expression by Foxp3(+) T Regulatory Cells is Not Essential for Their Suppressive Function in CNS Autoimmune Disease or Colitis. Front Immunol (2015) 0.93
Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. Proc Natl Acad Sci U S A (2002) 0.92
Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities. Immunology (2001) 0.90
Antigen-specific immunotherapy of autoimmune disease: a commentary. Clin Exp Immunol (1996) 0.90
T cell recognition of weak ligands: roles of signaling, receptor number, and affinity. Immunol Res (2011) 0.90
Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA. J Clin Invest (2014) 0.90
Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Nat Commun (2016) 0.89
Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis. PLoS One (2013) 0.89
The fate of T cells in the brain: veni, vidi, vici and veni, mori. Am J Pathol (1998) 0.89
A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells. J Immunol (2012) 0.89
Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE. J Neuroimmune Pharmacol (2009) 0.89
Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions. Immunology (1999) 0.88
T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int Rev Immunol (2006) 0.88
T-helper 1 dominated responses to erythrocyte Band 3 in NZB mice. Immunology (1996) 0.87
Regulatory T cell ablation causes acute T cell lymphopenia. PLoS One (2014) 0.87
Levees of immunological tolerance. Nat Immunol (2009) 0.85
Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J Immunol (2006) 0.85
Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation. Proc Natl Acad Sci U S A (2002) 0.85
Differential responses of CD45+ve T-cell subsets to MBP in multiple sclerosis. Clin Exp Immunol (2001) 0.84
Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC. Proc Natl Acad Sci U S A (2003) 0.84
Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread. J Immunol (2014) 0.84
Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy. Elife (2014) 0.83
Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat Rev Rheumatol (2015) 0.83
In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice. J Virol (2004) 0.82
CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin Exp Immunol (2012) 0.82
Bolus injection of aqueous antigen leads to a high density of T-cell-receptor ligand in the spleen, transient T-cell activation and anergy induction. Immunology (1998) 0.82
Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. J Biol Chem (2013) 0.81
Tolerating the nervous system: a delicate balance. J Exp Med (2000) 0.81
Transgenic models of autoimmune disease. Clin Exp Immunol (2002) 0.81
Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptide. Immunology (1999) 0.80
Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au. Int Immunol (2005) 0.80
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS. Neurol Neuroimmunol Neuroinflamm (2015) 0.80
Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy. Inflamm Allergy Drug Targets (2006) 0.80
Transplant tolerance: new insights and strategies for long-term allograft acceptance. Clin Dev Immunol (2013) 0.80
Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. Arthritis Res Ther (2006) 0.79
Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes. Diabetes (2008) 0.79
TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis. J Neuroinflammation (2012) 0.79
Single cell force spectroscopy of T cells recognizing a myelin-derived peptide on antigen presenting cells. Immunol Lett (2010) 0.78
Co-inhibitory molecules: Controlling the effectors or controlling the controllers? Self Nonself (2010) 0.78
The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response. PLoS One (2014) 0.78
Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells. PLoS One (2012) 0.78
Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans. Springer Semin Immunopathol (2005) 0.78
Protein kinase C theta is required for efficient induction of IL-10-secreting T cells. PLoS One (2017) 0.77
1,25-Dihydroxyvitamin D3-Conditioned CD11c+ Dendritic Cells are Effective Initiators of CNS Autoimmune Disease. Front Immunol (2015) 0.77
Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms. Front Cell Neurosci (2015) 0.77
Self-Antigen Presentation by Keratinocytes in the Inflamed Adult Skin Modulates T-Cell Auto-Reactivity. J Invest Dermatol (2015) 0.77
T cell avidity and tumor immunity: problems and solutions. Cancer Microenviron (2013) 0.77
Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal. J Exp Med (1998) 0.77
Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8⁺ T cells derived from autoantigen-deficient mice. Front Immunol (2011) 0.76
Immunotherapy in autoimmune type 1 diabetes. Rev Diabet Stud (2012) 0.76
Chloromycetin, a New Antibiotic From a Soil Actinomycete. Science (1947) 9.51
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J (1991) 8.31
Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell (1988) 5.73
Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A (1991) 5.52
"Infectious" transplantation tolerance. Science (1993) 4.98
Fix and flap: the radical orthopaedic and plastic treatment of severe open fractures of the tibia. J Bone Joint Surg Br (2000) 4.30
Unexpected relationships between four large deletions in the human beta-globin gene cluster. Cell (1983) 3.57
Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell (1989) 3.48
The evolution of alpha-fetoprotein and albumin. II. The structures of the alpha-fetoprotein and albumin genes in the mouse. J Biol Chem (1981) 3.26
Bird attack on milk bottles: possible mode of transmission of Campylobacter jejuni to man. Lancet (1990) 2.97
Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J Immunol Methods (1995) 2.86
Beta-globin gene inactivation by DNA translocation in gamma beta-thalassaemia. Nature (1984) 2.83
Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br (2000) 2.78
Locus control region function and heterochromatin-induced position effect variegation. Science (1996) 2.42
Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med (1998) 2.31
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30
The respiratory burst oxidase. J Biol Chem (1994) 2.29
The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development (2000) 2.22
The ocular impression: A review of the literature and presentation of an alternate technique. J Prosthodont (2000) 2.08
An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol (1993) 2.06
The structure of the human CD2 gene and its expression in transgenic mice. EMBO J (1988) 2.00
Gamma delta beta-thalassaemias 1 and 2 are the result of a 100 kbp deletion in the human beta-globin cluster. Nucleic Acids Res (1986) 1.90
Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J Virol (2000) 1.90
Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev Immunol (1993) 1.87
Embryonic expression and cloning of the murine GATA-3 gene. Development (1994) 1.84
Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol (1993) 1.82
Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol Today (1996) 1.81
Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev (1994) 1.80
Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol (1999) 1.78
Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med (1993) 1.71
Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation. J Gen Virol (1985) 1.70
Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J Am Chem Soc (1972) 1.69
Radiation exposure to the hands of orthopaedic surgeons: are we underestimating the risk? Arch Orthop Trauma Surg (2005) 1.64
Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol (1987) 1.62
Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest (1994) 1.60
Negative selection during the peripheral immune response to antigen. J Exp Med (2001) 1.59
The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells. J Exp Med (1996) 1.56
Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage. Cell (1991) 1.54
Bilateral anterior shoulder fracture-dislocation. A case report and a review of the literature. Int Orthop (1999) 1.53
The level of CD8 expression can determine the outcome of thymic selection. Cell (1992) 1.53
Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc Natl Acad Sci U S A (1992) 1.52
The presence of intervening sequences in the alpha-fetoprotein gene of the mouse. J Biol Chem (1979) 1.50
Random activation of a transgene under the control of a hybrid hCD2 locus control region/Ig enhancer regulatory element. EMBO J (1995) 1.49
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
Bad can act as a key regulator of T cell apoptosis and T cell development. J Exp Med (1999) 1.46
Friction burns within the tibia during reaming. Are they affected by the use of a tourniquet? J Bone Joint Surg Br (2002) 1.46
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1991) 1.45
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest (1995) 1.44
Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol (1997) 1.44
Segmental tibial fractures: an assessment of procedures in 27 cases. Injury (2003) 1.44
Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol (1991) 1.41
Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes (1992) 1.40
Heterochromatin protein 1 modifies mammalian PEV in a dose- and chromosomal-context-dependent manner. Nat Genet (1999) 1.40
An enhancing optic nerve lesion: malignant glioma of adulthood. Can J Ophthalmol (1997) 1.39
Regulation of CD40 function by its isoforms generated through alternative splicing. Proc Natl Acad Sci U S A (2001) 1.38
Nebulized bacteriostatic saline as a cause of bronchitis. J Fam Pract (1995) 1.38
Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (1997) 1.38
Measurement of volatile fatty acid production rates in the cecum of the pony. J Anim Sci (1976) 1.37
The natural occurrence of insulin receptors in groups on adipocyte plasma membranes as demonstrated with monomeric ferritin-insulin. J Supramol Struct (1977) 1.37
Nature of the genetic determinant controlling encapsulation in Staphylococcus aureus Smith. Infect Immun (1977) 1.35
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. J Clin Invest (1996) 1.33
Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. Immunity (2000) 1.33
Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures. An analysis of the second hit. J Bone Joint Surg Br (1999) 1.33
Ultrastructural localization of insulin receptors on adipocytes. Proc Natl Acad Sci U S A (1975) 1.32
Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo. Int Immunol (1999) 1.31
Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. J Immunol (1992) 1.30
The AXH module: an independently folded domain common to ataxin-1 and HBP1. FEBS Lett (2003) 1.29
Injury patterns associated with mortality following motorcycle crashes. Injury (2002) 1.29
Mite asthma. Cause and management. Practitioner (1970) 1.27
Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol (1993) 1.27
Electron microscopic demonstration of insulin receptors on adipocyte plasma membranes utilizing a ferritin-insulin conjugate. J Biol Chem (1974) 1.26
A region in the CD8 gene locus that directs expression to the mature CD8 T cell subset in transgenic mice. Immunity (1997) 1.26
Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs (2000) 1.26
Differential expression of human globin genes introduced in K562 cells. EMBO J (1985) 1.25
Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice. J Immunol (1994) 1.23
Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol (1999) 1.22
Insulin and alpha 2-macroglobulin-methylamine undergo endocytosis by different mechanisms in rat adipocytes: I. Comparison of cell surface events. J Cell Physiol (1987) 1.19
Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem (1999) 1.18
Visualization of cell-cell contact during conjugation in Streptococcus faecalis. J Bacteriol (1980) 1.18
Construction and cloning of rat albumin structural gene sequences. Proc Natl Acad Sci U S A (1979) 1.17
The functional outcome of severe, open tibial fractures managed with early fixation and flap coverage. J Bone Joint Surg Br (2004) 1.16
Dendritic cell maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848. Cell Immunol (1999) 1.16
Combining multileaf fields to modulate fluence distributions. Int J Radiat Oncol Biol Phys (1993) 1.15
Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clin Pharmacol Ther (2011) 1.15
Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest (1997) 1.14
Respiratory burst oxidase and three of four oxidase-related polypeptides are associated with the cytoskeleton of human neutrophils. J Clin Invest (1991) 1.13
Hierarchical interactions of control elements determine CD8alpha gene expression in subsets of thymocytes and peripheral T cells. Immunity (1998) 1.13
A minority of patients with rheumatoid arthritis show a dominant rearrangement of T-cell receptor beta chain genes in synovial lymphocytes. Scand J Immunol (1987) 1.13
Ca2+/calmodulin-dependent NO synthase type I: a biopteroflavoprotein with Ca2+/calmodulin-independent diaphorase and reductase activities. Biochemistry (1992) 1.13
Complex lymphoid and epithelial thymic tumours in Thy1-myc transgenic mice. Nature (1989) 1.13
Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity. Int Immunol (1995) 1.13
Reamed against unreamed nailing of the femoral diaphysis: a retrospective study of healing time. Injury (1997) 1.12
Human HMG box transcription factor HBP1: a role in hCD2 LCR function. EMBO J (1999) 1.12
Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects. J Biol Chem (1987) 1.11
Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally. Early Hum Dev (1986) 1.11
Adjuvant activities of immune response modifier R-848: comparison with CpG ODN. Cell Immunol (2000) 1.10
Glucocorticoids attenuate T cell receptor signaling. J Exp Med (2001) 1.10
Health-related behaviours as predictors of mortality and morbidity in Australian Aborigines. Prev Med (2006) 1.09
Fluoroscopy-based multiplanar image guidance for insertion of sacroiliac screws. Clin Orthop Relat Res (2002) 1.09